Patent Drawing in Melbourne.

A patent drawing Melbourne applicant files is examined in Canberra and enforced three blocks from Flagstaff Station. IP Australia takes everything electronically; the dispute lands in the Federal Court of Australia’s Victoria District Registry at 305 William Street. Between those two points sits the thing that actually distinguishes Melbourne work from the rest of the country: this is Australia’s life-sciences capital, and life-sciences figures are the hardest figures in the Australian system. PerspireIP prepares drawings for the Parkville precinct, Monash, CSL’s supply chain and the Victorian agritech and advanced-manufacturing base — and we build them to the instrument that actually applies, which is no longer Schedule 3.

Which rules govern a patent drawing Melbourne applicant files

There is no patent office in Melbourne. Australian standard patents are examined and granted by IP Australia in Canberra, which accepts filings electronically from anywhere. So the Melbourne connection is in the attorneys, the research institutions and the court — not a local filing counter.

The formal requirements for your sheets are where most checklists go wrong. They are not in Schedule 3 of the Patents Regulations 1991 any more. They were lifted out into a determination made under section 229(1) of the Patents Act 1990, and the filing date decides which version binds you: Schedule 3 for applications filed before 24 February 2019, the Formalities Determination 2019 for 24 February 2019 to 30 June 2022, and the Formalities Determination 2022 for anything filed on or after 1 July 2022.

The geometry itself is the familiar PCT-derived set. Sheets are A4, with minimum margins of 2.5 cm top, 2.5 cm left, 1.5 cm right and 1 cm bottom, and every figure must sit inside a 26.2 cm × 17.0 cm useable surface. One prohibition catches almost everyone: the sheet must not contain a frame around the drawings or around the useable surface. Border lines and title blocks are defaults in most CAD templates, and they are the most common avoidable objection on an Australian figure set.

Drawing sheets are numbered on their own sequence — two Arabic numerals separated by an oblique stroke, as in 2/10 — and figures may not appear in the patent request, the description or the claims. We set the whole Australian position out in our guide to patent drawings in Australia.

The 1 July 2022 double change Melbourne biotech filers keep missing

Two separate changes landed on the same day, and for a Parkville or Clayton filing they interact. 1 July 2022 brought the Formalities Determination 2022 — and it brought WIPO Standard ST.26, which all WIPO member states implemented simultaneously at the international, regional and national levels in a single big-bang transition.

ST.26 matters to a drawing brief because of what it takes out of the drawings. Nucleotide and amino acid sequence listings are no longer the plain-text ST.25 attachments some older families carry; they must be filed as a compliant XML sequence listing. A sequence is not a figure, and it should never be pasted into a drawing sheet to make a page count work. If your invention is a biologic, a construct or a CAR-T binder, the sequence data leaves the figure set entirely and the drawings carry the structural and functional story instead.

There is a trap worth docketing. The filing date governs, not the priority date — and a divisional or continuing application with a filing date on or after 1 July 2022 must comply with ST.26 even where its parent was filed on or before 30 June 2022. Melbourne institutes run long divisional chains off pre-2022 parents, so this comes up constantly. Converting an ST.25 listing is not a formatting pass; it is a re-annotation exercise, and it has to be done without adding matter.

The practical sequencing for a Melbourne life-sciences filing is therefore: settle the sequence listing in ST.26 XML first, then decide what the figures still need to show, then build the sheets. Done in that order, the drawing set gets smaller and clearer. Done backwards, you pay twice.

Gels, micrographs and colour: the indispensability test

Life-sciences figures are rarely line drawings. They are Western blots, histology sections, immunofluorescence panels, flow cytometry plots and electron micrographs — and the question is whether IP Australia will take them.

Under the current determination it generally will, on a necessity test. Graphics and photographs are permitted where a drawing cannot represent the information, and colour is permitted where it is indispensable to understanding the invention. There is no petition and no surcharge. IP Australia’s own practice guidance adds three useful qualifications: a full description of an invention rarely requires colour, the office expects black and white wherever that is possible, and where colour genuinely matters a standard colour reference chart such as the Royal Horticultural Society chart may serve instead — a real option for plant and pigment cases out of the Victorian agritech base.

Compare what the same panel costs you elsewhere. In a US utility application, 37 CFR 1.84(a)(2) requires a granted petition plus the fee under 37 CFR 1.17(h) plus a prescribed paragraph inserted at the head of the brief description of the drawings; 37 CFR 1.84(b)(1) treats photographs as not ordinarily permitted and admits them only as the only practicable medium. The EPO has accepted electronically filed colour and greyscale drawings since 1 October 2025, provided they are contrast-rich at 300 dpi.

The constraint that usually decides it is upstream of all three. PCT Rule 11.13(a) still requires black lines “without colorings”, and most Melbourne cases reach Australia through the PCT. If the international application went in monochrome, the Australian national-phase figures are monochrome too — whatever the determination would have allowed on a direct filing. That is a decision to make at the international filing, not at 31 months.

Where figures meet sufficiency under section 40

IP Australia is notably relaxed about form. Its manual states that strict compliance with the formalities requirements for specifications is not required, and that there is no need to raise an objection where the documents substantially comply. A slightly light line weight or an inconsistent numeral font will usually pass in Canberra where it would draw a notice of non-compliant drawings in Alexandria.

Do not mistake that for latitude about content. Section 40(2)(a) of the Patents Act 1990 requires the complete specification to disclose the invention in a manner that is clear enough and complete enough for the invention to be performed by a person skilled in the relevant art — the standard introduced by the Intellectual Property Laws Amendment (Raising the Bar) Act 2012, which applies to applications whose examination was requested on or after 15 April 2013.

Figures sit squarely inside that test for life-sciences cases. An unlabelled axis, a micrograph with no scale bar, a construct map whose elements do not match the sequence listing, or a figure legend that contradicts the description are not formalities problems that substantial compliance will absorb. They are disclosure problems, and they surface in examination, in pre-grant opposition and — years later — in a revocation cross-claim.

The rule of thumb we work to: build the sheets to the strictest formal standard in the family so one set clears every office, and treat every figure as a disclosure document that a hostile expert will read aloud in court.

Where a Melbourne patent is actually enforced

Australian patent litigation is federal. State courts do not hear it. The Federal Court of Australia has the jurisdiction, and in Victoria it sits in the Owen Dixon Commonwealth Law Courts Building, 305 William Street, Melbourne, on the corner of William and La Trobe Streets opposite Flagstaff Gardens. The same building houses the Melbourne registry of the High Court of Australia.

Cases are managed through the Federal Court’s Intellectual Property National Practice Area, which puts patent matters before judges who hear them routinely rather than occasionally. Infringement and validity are heard together, with validity usually run as a revocation cross-claim, so the figures are in evidence from the first case-management hearing. Appeals go to the Full Court of the Federal Court, and from there to the High Court of Australia only by special leave.

Before any of that, there is an earlier exposure. Australian opposition is pre-grant: acceptance is advertised and third parties have three months to oppose. For a contested biologic or medical-device case out of Melbourne, that opposition is frequently the first time an opponent’s expert reads your figures line by line.

Note also what is not available. Australia is not a European Patent Convention state, so there is no validating a European patent into Australia and the Unified Patent Court has no reach here. Protection comes from a direct national filing or PCT national-phase entry, which is due at 31 months from earliest priority rather than the 30 months most dockets default to.

The Melbourne industries that actually drive local filings

Melbourne’s filing profile is not a generic capital-city mix. It is dominated by one cluster and three supporting ones, and each produces a recognisably different figure set.

• Biotechnology and biologics. The Parkville biomedical precinct — the Walter and Eliza Hall Institute, the Peter MacCallum Cancer Centre, the Doherty Institute, the Bio21 Institute and the University of Melbourne — sits alongside CSL, Australia’s largest biotechnology company. Output: construct maps, binding and efficacy plots, flow cytometry panels, histology. This is where ST.26 and the colour rules bite hardest.
• Medical devices and diagnostics. Clinical-engineering spin-outs and diagnostics companies across the inner north and south-east. Output: assembled and exploded device views, sectional views, circuit and signal-path diagrams, often with a software claim set attached.
• Advanced manufacturing. Volume car-making in Victoria ended in 2017, and the engineering base pivoted into precision components, additive manufacturing, defence and rail. Output: classic mechanical figure sets — sectional views, hatching, tolerancing cues.
• Agritech. Victorian agricultural research and plant science, including plant-variety work where colour is genuinely load-bearing and the RHS colour chart becomes the practical route.

Two of those four groups file predominantly through universities and medical research institutes, which matters for drawings in a specific way: the figures arrive as publication-grade panels prepared for a journal, not as patent sheets. Journal panels carry frames, composite lettering, multi-part labels and colour that does not survive a monochrome conversion. Converting them properly — rather than cropping and hoping — is most of the work on a Melbourne institutional filing.

Why figure quality compounds on long-lived Melbourne pharma cases

There is a structural reason to over-invest in figures on a Melbourne pharmaceutical or biologic filing: those patents live longer than anyone else’s.

An Australian standard patent runs 20 years from its filing date. For a pharmaceutical substance, Part 3 of Chapter 6 of the Patents Act 1990 (sections 70 to 79A) allows an extension of term of up to 5 years, giving a maximum effective term of 25 years. The gateway conditions are narrow — a pharmaceutical substance per se must be in substance disclosed in the specification and fall within the claims, the substance must be included in the Australian Register of Therapeutic Goods, and first regulatory approval must have come more than five years after the patent date.

Compound that over 25 years and the consequence is obvious. A figure drawn today for a CSL-adjacent filing may be construed by a Federal Court judge in the 2040s, against a generic or biosimilar entrant with every incentive to read an ambiguous panel narrowly. Figures are the part of a specification that ages worst, because the person who drew them is long gone and the raw data is often irrecoverable.

The cheap insurance is boring: label every axis and scale bar, keep reference numerals consistent between description and drawings in both directions, archive the source files alongside the filed sheets, and never let a figure assert something the description does not also say in words.

What a patent drawing Melbourne project includes

We work from whatever you have — CAD files, journal figure panels, construct maps, photographs, instrument exports or hand sketches — and return filing-ready sheets plus editable sources.

• Instrument check first. We confirm the application’s filing date and therefore whether Schedule 3, the 2019 determination or the Formalities Determination 2022 applies before drawing anything.
• One master set, every office. Sheets built to satisfy IP Australia, 37 CFR 1.84 and the current EPO standard simultaneously, so a Melbourne filing and its US and European counterparts do not need redrawing.
• Life-sciences conversion. Journal-grade panels rebuilt as patent figures: frames stripped, lettering rebuilt to a legible minimum, colour either justified as indispensable or converted to distinguishable monochrome without losing the distinction the panel was making.
• Sequence-listing coordination. We keep figure labels consistent with your ST.26 XML listing, so construct maps and the listing do not contradict each other.
• Reference-numeral audit. Every numeral in the description checked against the drawings and the reverse, which is the single most common source of a clarity objection.
• Design representations handled separately. Australia has no design patent; appearance is protected as a registered design under the Designs Act 2003, whose representations follow their own 2022 instrument, so those are prepared to a different specification.

Eight checks before a Melbourne filing goes out: the right formalities instrument for the filing date; A4 with 2.5/2.5/1.5/1 cm margins; everything inside the 26.2 cm × 17.0 cm useable surface; no frame; monochrome unless colour is indispensable, and monochrome regardless if the case came via the PCT; no text beyond indispensable words; drawing sheets numbered 2/10 style with no figures in the request, description or claims; and sequences in ST.26 XML rather than on a drawing sheet.

See our full Patent Drawing services, the companion Patent Drawing in Sydney page, and our wider IP services in Australia.

IP Landscape & Resources in Melbourne

Key intellectual-property authorities and venues relevant to Melbourne:

• IP Australia — examines and grants Australian standard patents and registers designs, administering the Patents Act 1990, the Patents Regulations 1991 and the Formalities Requirements for Patent Documents Determination 2022
• Federal Court of Australia — hears Australian patent infringement and revocation proceedings through its Intellectual Property National Practice Area, with the Victoria District Registry in the Owen Dixon Commonwealth Law Courts Building at 305 William Street, Melbourne
• WIPO Standard ST.26 — the XML sequence-listing standard implemented simultaneously by WIPO member states for applications filed on or after 1 July 2022, replacing the earlier ST.25 text format

Request Patent Drawings for a Melbourne Filing

Explore related PerspireIP services: Patent Drawing services · Patent Drawings in Australia · IP services in Australia · Patent Drawing in Sydney.

Frequently Asked Questions